Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hidaka, E.
Right arrow Articles by Kato, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hidaka, E.
Right arrow Articles by Kato, Y.
[Cancer Research 60, 522-524, February 1, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

High Frequency of K-ras Mutations in Biliary Duct Carcinomas of Cases with a Long Common Channel in the Papilla of Vater1

Eiji Hidaka, Akio Yanagisawa2, Makoto Seki, Kouichi Takano, Toshiaki Setoguchi and Yo Kato

Departments of Pathology [E. H., A. Y., Y. K.], Surgery [M. S.], and Internal Medicine [K. T.], Cancer Institute, Tokyo 170-8455; and Department of Surgery I, Miyazaki Medical College, Miyazaki, 889-1692 [E. H., T. S.], Japan

The frequency of K-ras mutation in biliary duct carcinomas in different locations and the relationship to the form of the junction of the pancreaticobiliary duct (JPBD) are not understood clearly. These points were investigated in the present study. Thirty-seven biliary duct carcinomas in patients without anomalous JPBD were investigated for K-ras mutations. Regarding location, 12 were hilar, 4 in the upper, 11 in the middle, and 10 in the lower portion of the duct. Furthermore, with 14 cases for which the form of the JPBD could be confirmed by endoscopic retrograde cholangiopancreatography or postoperative cholangiopancreatography, division was made into two types: those with a long common channel (>5 mm) in the papilla of Vater (type 1, n = 4), and the other with a shorter or nonapparent common channel (type 2, n = 10). The overall frequency of K-ras mutation was 30%, the incidence gradually increasing from upper to lower regions. K-ras mutations were significantly more frequent in biliary duct carcinomas associated with long common channels (P < 0.05). These results suggest that a long common channel may bear a relation to K-ras mutations in biliary duct carcinogenesis, presumably through its influence on pancreatic juice regurgitation.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
K. Soreide and J. A. Soreide
Bile Duct Cyst as Precursor to Biliary Tract Cancer
Ann. Surg. Oncol., March 1, 2007; 14(3): 1200 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C.-Y. Chen, S.-C. Shiesh, and S.-J. Wu
Rapid Detection of K-ras Mutations in Bile by Peptide Nucleic Acid-mediated PCR Clamping and Melting Curve Analysis: Comparison with Restriction Fragment Length Polymorphism Analysis
Clin. Chem., March 1, 2004; 50(3): 481 - 489.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Rashid, T. Ueki, Y.-T. Gao, P. S. Houlihan, C. Wallace, B.-S. Wang, M.-C. Shen, J. Deng, and A. W. Hsing
K-ras Mutation, p53 Overexpression, and Microsatellite Instability in Biliary Tract Cancers: A Population-based Study in China
Clin. Cancer Res., October 1, 2002; 8(10): 3156 - 3163.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Kiguchi, S. Carbajal, K. Chan, L. Beltran, L. Ruffino, J. Shen, T. Matsumoto, N. Yoshimi, and J. DiGiovanni
Constitutive Expression of ErbB-2 in Gallbladder Epithelium Results in Development of Adenocarcinoma
Cancer Res., October 1, 2001; 61(19): 6971 - 6976.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E Hidaka, A Yanagisawa, M Seki, T Setoguchi, and Y Kato
Genetic alterations and growth pattern in biliary duct carcinomas: loss of heterozygosity at chromosome 5q bears a close relation with polypoid growth
Gut, May 1, 2001; 48(5): 656 - 659.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.